1Ihle JN.The STAT family in cytokine signaling.Curr Opin Cell Biol,2001,13(2):211-217.
2Bowman T,Garcia R,Turkson J,et al.STATs in oncogenesis.Oncogene,2000,19 (21):2474-2488.
3Christodoulopoulos P,Cameron L,Nakamura Y,et al.Th2 cytokine-associated transcription factors in atopic and nonatopic asthma:Evidence for differential singal transducer and activator of transcription6 expression.J AllergyClin Immunol,2001,107(4):586-591.
4Di Stefano A,Caramori G,Ricciardolo FL,et al.Cellular and molecular mechanisms in chronic obstructive pulmonary disease.Clin Exp Allergy,2004,34(8):1156-1167.
5Cosio MG.Autoimmunity,T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease.Eur Respir J,2004,24(11):3-5.
6Moodley YP,Scaffidi AK,Misso NL,et al.Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation.Am J Pathol,2003,163 (1):345-354.
7Severgnini M,Takahashi S,Rozo LM,et al.Activation of the STAT pathway in acute lung injury.Am J Physiol Lung Cell Mol Physiol,2004,286 (6):L1282-L1292.
8Nelson V,Davis GE,Maxwell SA.A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53mediated transactivation but notapoptosis.Apoptosis,2001,6 (3):221-234.
9Levy DE,Gilliland DG.Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptionsin mice.Oncogene,2000,19(21):2505-2510.
10Frantsve J,Schwaller J,Sternberg DW,et al.Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK kinase activity and induction of proteasome-mediated degradation.Mol Cell Biol,2001,21 (10):3547-3557.
9Meduri GU,Carratu P,Freire AX.Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS.Eur Respir J Suppl,2003,42:57s-64s.
10Benkhart EM,Siedlar M,Wedel A,et al.Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression.J Immunol,2000,165(3):1612-1617.
